Abeona Therapeutics (ABEO) SVP sells shares to cover tax obligations
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Abeona Therapeutics SVP and Chief Legal Officer Brendan M. O'Malley sold 12,050 shares of common stock on July 9, 2026 at a weighted average price of $6.9637 per share.
The company notes this sale was made to cover tax obligations from vesting of restricted stock awards. After the sale, O'Malley directly holds 427,953 shares of Abeona Therapeutics common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 12,050 shares ($83,913)
Net Sell
1 txn
Insider
O'Malley Brendan M.
Role
SVP, Chief Legal Officer
Sold
12,050 shs ($84K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 12,050 | $6.9637 | $84K |
Holdings After Transaction:
Common Stock — 427,953 shares (Direct, null)
Footnotes (1)
- The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Key Figures
Shares sold: 12,050 shares
Weighted average sale price: $6.9637 per share
Post-transaction holdings: 427,953 shares
+1 more
4 metrics
Shares sold
12,050 shares
Open-market sale on July 9, 2026
Weighted average sale price
$6.9637 per share
Common stock sale on July 9, 2026
Post-transaction holdings
427,953 shares
Shares directly held by O'Malley after sale
Sale price range
$6.86–$7.04 per share
Prices for multiple transactions included in the sale
Key Terms
restricted stock awards, weighted average price, open-market sale
3 terms
restricted stock awards financial
"cover tax obligations associated with the vesting of restricted stock awards"
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did Abeona Therapeutics (ABEO) insider Brendan O'Malley report on this Form 4?
Brendan M. O'Malley, Abeona Therapeutics’ SVP and Chief Legal Officer, reported selling 12,050 shares of common stock. The company states the sale was executed to cover tax obligations from the vesting of restricted stock awards.